MassMutual Private Wealth & Trust’s ADMA Biologics ADMA Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.51K	Sell	181 -42	-19%	-$383	﹤0.01%	2076
2026 Q1	$2.01K	Buy	223 +3	+1%	+$47	﹤0.01%	1977
2025 Q4	$4.01K	Buy	220 +101	+85%	+$1.7K	﹤0.01%	1768
2025 Q3	$1.75K	Sell	119 -269	-69%	-$4.61K	﹤0.01%	2022
2025 Q2	$7.07K	Buy	388 +38	+11%	+$775	﹤0.01%	1491
2025 Q1	$6.94K	Buy	350 +132	+61%	+$2.28K	﹤0.01%	1445
2024 Q4	$3.74K	Buy	218 +48	+28%	+$903	﹤0.01%	1635
2024 Q3	$3.4K	Buy	170 +135	+386%	+$2.1K	﹤0.01%	1495
2024 Q2	$391	Hold	35	–	–	﹤0.01%	1991
2024 Q1	$231	Buy	+35	New	+$191	﹤0.01%	1977

Other funds holding ADMA

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

MCM

Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return

Ruffer LLP London, United Kingdom $2.83B AUM 30.34% 1-Year Est. Return

PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

MassMutual Private Wealth & Trust's ADMA Position: Q2 2026 in Review

MassMutual Private Wealth & Trust reduced its ADMA Biologics (ADMA) stake by 19% in Q2 2026, selling an estimated $383 and leaving 181 shares worth $1.51K. The position accounts for ﹤0.01% of the portfolio, ranked #2076.

MassMutual Private Wealth & Trust first reported a position in ADMA in Q1 2024 and has held it in 10 quarters since. The position peaked at $7.07K in Q2 2025. 81 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

MassMutual Private Wealth & Trust held 181 shares of ADMA Biologics worth $1.51K as of Q2 2026.
MassMutual Private Wealth & Trust sold 42 ADMA Biologics shares in Q2 2026, an estimated $383.
ADMA Biologics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #2076 holding.
MassMutual Private Wealth & Trust first reported a position in ADMA Biologics in Q1 2024 and has held it in 10 quarters since.
MassMutual Private Wealth & Trust's ADMA Biologics position peaked at $7.07K in Q2 2025.
81 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.